Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1215603.RAxt_IBcWrJTTzOMKLWXW744d-N6T464uXn9YiKkWEfGQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1215603.RAxt_IBcWrJTTzOMKLWXW744d-N6T464uXn9YiKkWEfGQ130_assertion type Assertion NP1215603.RAxt_IBcWrJTTzOMKLWXW744d-N6T464uXn9YiKkWEfGQ130_head.
- NP1215603.RAxt_IBcWrJTTzOMKLWXW744d-N6T464uXn9YiKkWEfGQ130_assertion description "[Sorafenib and nilotinib resensitize tamoxifen resistant breast cancer cells to tamoxifen treatment via estrogen receptor ?.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1215603.RAxt_IBcWrJTTzOMKLWXW744d-N6T464uXn9YiKkWEfGQ130_provenance.
- NP1215603.RAxt_IBcWrJTTzOMKLWXW744d-N6T464uXn9YiKkWEfGQ130_assertion evidence source_evidence_literature NP1215603.RAxt_IBcWrJTTzOMKLWXW744d-N6T464uXn9YiKkWEfGQ130_provenance.
- NP1215603.RAxt_IBcWrJTTzOMKLWXW744d-N6T464uXn9YiKkWEfGQ130_assertion SIO_000772 25175082 NP1215603.RAxt_IBcWrJTTzOMKLWXW744d-N6T464uXn9YiKkWEfGQ130_provenance.
- NP1215603.RAxt_IBcWrJTTzOMKLWXW744d-N6T464uXn9YiKkWEfGQ130_assertion wasDerivedFrom befree-2016 NP1215603.RAxt_IBcWrJTTzOMKLWXW744d-N6T464uXn9YiKkWEfGQ130_provenance.
- NP1215603.RAxt_IBcWrJTTzOMKLWXW744d-N6T464uXn9YiKkWEfGQ130_assertion wasGeneratedBy ECO_0000203 NP1215603.RAxt_IBcWrJTTzOMKLWXW744d-N6T464uXn9YiKkWEfGQ130_provenance.